Results 241 to 250 of about 131,644 (347)

Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3

Diabetes, Obesity and Metabolism, Volume 27, Issue 12, Page 7110-7122, December 2025.
Abstract Aims This post hoc analysis assessed the efficacy and safety data in tirzepatide‐treated Korean patients with type 2 diabetes (T2D). Materials and Methods Data specifically from Korean patients treated with tirzepatide 5, 10, or 15 mg in the multicentre, randomised, open‐label, parallel‐group, phase 3 trials SURPASS‐AP‐Combo and SURPASS‐3 were
Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn   +11 more
wiley   +1 more source

A Pilot Analysis of Bioparameters in Patients with Dyspepsia Accompanied by Abdominal Hardness: An Exploration of <i>Damjeok</i> Syndrome Rooted in Traditional Medicine. [PDF]

Healthcare (Basel)
Lim YS, Son CG, Lee JH, Yang SD, Park D, Rho GH, Choi GH, Choi SH.   +7 more
europepmc   +1 more source

Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials

Diabetes, Obesity and Metabolism, Volume 27, Issue 12, Page 7344-7354, December 2025.
Abstract Aims Incretin agonists are used to treat obesity and metabolic dysfunction. Instead of systemically delivering high levels of hormone receptor agonists that can lead to adverse effects, we tested and optimized oral microbead formulations that activate endogenous enteroendocrine signalling systems via distal nutrient‐sensing cells.
Kai Deusch, Arthur Deboek, Christian Sina, Coral Capo‐Velez, Vivianette Alicea, Stephan Duller, Susanne Grafe, Darcy Lidington, Julia Hanchard, Steffen‐Sebastian Bolz   +9 more
wiley   +1 more source

Comparison of Glycemic and Anthropometric Parameters Among Patients With Dyspepsia and Dyslipidemia With or Without Helicobacter pylori Infection: A Cross-Sectional Study. [PDF]

Cureus
Serra MAA, Torres MD, Rolins Neto PR, de Sousa MVP, Serra Dos Santos CAA, Pascoal LM, Neto MS, Dos Santos LH, de Araujo MFM.   +8 more
europepmc   +1 more source

Discussion on "The Treatment of Functional Dyspepsia.".

, 1908
Hutchison
openalex   +1 more source

The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint

Journal of Gastroenterology and Hepatology, Volume 40, Issue 12, Page 2890-2897, December 2025.
ABSTRACT Background and Aim Irritable bowel syndrome with constipation (IBS‐C) is characterized by multiple sensory symptoms, including abdominal pain, bloating, and bowel habit alterations. Therapeutic response should address all components. This study assesses a new exploratory trisymptom composite efficacy endpoint in an IBS‐C population of young ...
Darren M. Brenner, Andrea S. Shin, Adam P. Laitman, Jill K. Deutsch, David C. Kunkel   +4 more
wiley   +1 more source

Effect of STW 5-II (Iberogast-N) on Tolerance to Gastric Gas in Patients With Functional Dyspepsia. The IBO-2 Study. [PDF]

Neurogastroenterol Motil
Aguilar A, Alcala-Gonzalez L, Barber C, Santos J, Lobo B, Malagelada C, Serra J.   +6 more
europepmc   +1 more source

Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis

Journal of Internal Medicine, Volume 298, Issue 6, Page 617-625, December 2025.
Abstract Background Due to the expanding screening of coeliac disease (CeD), low positive and borderline negative serum transglutaminase 2 antibody (TGA) values are causing increasing confusion in clinical practice. Objectives To investigate the significance of these findings in a well‐defined patient cohort. Methods Altogether 311 IgA‐competent adults,
Rakel Nurmi, Celina Turunen Beteta, Kalle Kurppa, Heini Huhtala, Katri Lindfors, Laura Kivelä, Katri Kaukinen, Saana Paavola   +7 more
wiley   +1 more source

Comparative evaluation of two herbal formulas for gastrointestinal function and gut microbiota modulation in rats with loperamide-induced dyspepsia. [PDF]

Sci Rep
Khakisahneh S, Wang JH, Zhang XY, Choi Y, Han SY, Song EJ, Nam YD, Kim H.   +7 more
europepmc   +1 more source

FATIGUE DYSPEPSIA [PDF]

BMJ, 1915
openaire   +2 more sources